Novel Antihypertensive Reduced Blood Pressure in Primary Aldosteronism

(MedPage Today) — An investigational antihypertensive drug resolved or reduced hypertension in patients with primary aldosteronism, according to a small phase IIa trial.
By week 12, systolic blood pressure was reduced by a mean of 24.9 mm Hg…